Apolarion
Switzerland
◆ About Apolarion
Develops plasma-based solutions to protect seeds from harmful pathogens while reducing environmental impact in agriculture.
◆ What sets it apart
Its modular cold-plasma treatment generates pathogen-neutralizing reactive particles from only air and electricity, avoiding toxic chemicals, water, and high heat while maintaining seed germination potential.
◆ Sectors
◆ Business
Modelhardware
CustomerSeed companies and agricultural growers, initially focusing on high-value vegetable seeds and organic producers
◆ Notable
- EPFL spin-off from the Swiss Plasma Center
- Received CHF 150,000 from Venture Kick in 2026
- Received an EPFL Innogrant sponsored by UBS
- Developed a modular prototype and progressed toward initial field trials and customer deployments
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Apolarion do?
Develops plasma-based solutions to protect seeds from harmful pathogens while reducing environmental impact in agriculture.
Where is Apolarion based?
Apolarion is based in Switzerland.
How much has Apolarion raised?
Apolarion has raised $0.2M in tracked funding and is currently at the seed stage.
Who has invested in Apolarion?
Investors in Apolarion include Venture Kick, EPFL Innogrant and UBS.